‘Coping With Cancer in Early Adulthood’ addresses issues of patients 18 to 49 years old. A new book aims to educated young ...

Caregivers must respect the autonomy of adult patients, balancing support with allowing them to lead their own cancer journey ...

The subsequent treatment involved intensive procedures, including five rounds of chemotherapy, external beam radiation, and ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...

While October promotes awareness through campaigns, ribbons and fundraising, survivors report a more complex reality. Breast cancer survivor Maureen Green described the month as a reminder of the ...

PhD in clinical psychology. She is a senior psychologist, director of Interprofessional Education and director of the Young Adult Program (YAP) in the Department of Supportive Oncology at Dana-Farber ...

“Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers,” by Dewpoint Therapeutics. News release; Oct. 21, 2025. For more news on cancer ...

CURE had the privilege of attending the Hairy Cell Leukemia Foundation 2025 Conference in Bologna, Italy, where medical experts gathered to discuss advances in research, treatment ...

CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care.

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay ...

HR-positive/HER2-negative breast cancer grows with estrogen or progesterone, lacking high HER2 protein levels, making hormone ...

Stephanie Wachtel found empowerment and control through areola tattooing, enhancing her sense of normalcy after breast cancer ...